首页 > 最新文献

Pharmacy & Pharmacology International Journal最新文献

英文 中文
Pilot study to compare the use of the national program drugs ALONE versus their combination with Artemisia Afra infusions for the treatment of pulmonary tuberculosis 比较单独使用国家规划药物与与非洲蒿注射液联合使用治疗肺结核的试点研究
Pub Date : 2023-09-11 DOI: 10.15406/ppij.2023.11.00410
Pascal Gisenya, Patrick E Ogwang, Elkan Katotola, Adele Ntezahorigwa, Claudette Ndayininahaze
{"title":"Pilot study to compare the use of the national program drugs ALONE versus their combination with Artemisia Afra infusions for the treatment of pulmonary tuberculosis","authors":"Pascal Gisenya, Patrick E Ogwang, Elkan Katotola, Adele Ntezahorigwa, Claudette Ndayininahaze","doi":"10.15406/ppij.2023.11.00410","DOIUrl":"https://doi.org/10.15406/ppij.2023.11.00410","url":null,"abstract":"","PeriodicalId":19839,"journal":{"name":"Pharmacy & Pharmacology International Journal","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135938147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Gender differences in MS related pain, correlation with MRI lesion localization and burden of disease MS相关疼痛的性别差异,与MRI病变定位和疾病负担的相关性
Pub Date : 2021-12-17 DOI: 10.15406/ppij.2021.09.00354
M. Avila, V. Neugebauer, J. DeToledo
Multiple Sclerosis (MS) is an inflammatory demyelinating disorder of the central nervous system (CNS). It is the most common cause of acquired neurologic dysfunction in young patients. It is an autoimmune condition and is more prevalent in woman.1 The incidence of MS in the United States is approximately 85-100 cases per 100,000 people per year. The ratio of women to men has been estimated to be 2.6:1.1 The evaluation and diagnosis of MS is critically dependent on the findings of Magnetic Resonance Imaging (MRI). Characteristically MS plaques are multiple, hyperintense in T2 weighted images and Fluid Attenuated Inversion Recovery (FLAIR). Hypointense lesions in T1-WI are associated with areas of myelin loss.2 Brain MRI is important in treatment decisions as lesions may be clinically silent.
多发性硬化症(MS)是一种中枢神经系统(CNS)的炎症性脱髓鞘疾病。它是年轻患者获得性神经功能障碍的最常见原因。这是一种自身免疫性疾病,在女性中更为普遍在美国,多发性硬化症的发病率约为每年每10万人中85-100例。女性与男性的比例估计为2.6:1.1。MS的评估和诊断严重依赖于磁共振成像(MRI)的结果。典型的MS斑块是多发的,T2加权图像和液体衰减反转恢复(FLAIR)呈高强度。T1-WI的低信号病变与髓磷脂丢失有关脑MRI在治疗决策中很重要,因为病变可能在临床上无症状。
{"title":"Gender differences in MS related pain, correlation with MRI lesion localization and burden of disease","authors":"M. Avila, V. Neugebauer, J. DeToledo","doi":"10.15406/ppij.2021.09.00354","DOIUrl":"https://doi.org/10.15406/ppij.2021.09.00354","url":null,"abstract":"Multiple Sclerosis (MS) is an inflammatory demyelinating disorder of the central nervous system (CNS). It is the most common cause of acquired neurologic dysfunction in young patients. It is an autoimmune condition and is more prevalent in woman.1 The incidence of MS in the United States is approximately 85-100 cases per 100,000 people per year. The ratio of women to men has been estimated to be 2.6:1.1 The evaluation and diagnosis of MS is critically dependent on the findings of Magnetic Resonance Imaging (MRI). Characteristically MS plaques are multiple, hyperintense in T2 weighted images and Fluid Attenuated Inversion Recovery (FLAIR). Hypointense lesions in T1-WI are associated with areas of myelin loss.2 Brain MRI is important in treatment decisions as lesions may be clinically silent.","PeriodicalId":19839,"journal":{"name":"Pharmacy & Pharmacology International Journal","volume":"96 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75934702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy and safety of silodosin-a review of literature 西洛多辛的疗效和安全性——文献综述
Pub Date : 2021-12-16 DOI: 10.15406/ppij.2021.09.00353
Gokhan Faikoglu, Kubra Saygisever-Faikoglu, Fatmanur Otmar Ozcan, B. Berk
clinical global ejaculation latency times; IPSS, international prostate symptom score; lower urinary tract lower urinary benign MCC, maximum cystometric capacity; postvoid residual urine volume; Rej, retrograde ejaculation; transurethral incision of the prostate; Background: Benign prostatic hyperplasia is a compilation of irritative voiding and obstructive symptoms which are consistent with reduced emptying of urine from and defective storage of urine in the bladder. Medications are a common method of treatment to delay complications and reduce symptoms. Silodosin is a highly selective alpha-1A adrenoceptor blocker that has 162 times more affinity for alpha-1a than alpha 1b, thus resulting in high uroselectivity and decreased side effects. Aim: In this review article our aim was to elucidate the clinical effects, safety and tolerability profile of silodosin in the treatment of benign prostatic hyperplasia. Method: Literatures were retrieved by a PubMed search, using different combinations of pertinent keywords (e.g., silodosin, hypotension, benign prostatic hyperplasia), without any limitations in terms of publication date and language. Papers which assessed the therapeutic efficacy and tolerability of silodosin were selected for inclusion according to their relevance for the topic, as judged by the authors. Overvıew of clinical data: Silodosin is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia. It has a rapid onset of effect in men with lower urinary tract symptoms and improvements were seen in voiding and storage symptoms, maximum urinary flow rate and health-related quality of life. The efficacy of silodosin was maintained in several controlled studies and also non-interventional real-world setting. Silodosin was generally well tolerated. Conclusion: Silodosin is the most uroselective α-blocker. Silodosin has been emphasized in the 2021 European Association of Urology Conservative treatment of non-neurogenic male LUTS guidelines and it has been reported that the hypotensive effect of silodosin is comparable with placebo and has favorable safety and tolerability profile. Dosing of silodosin does not need to be adjusted according to age, concurrent medication with antihypertensives and phosphodiesterase type 5 inhibitors.
临床全球射精潜伏期;IPSS:国际前列腺症状评分;下尿路下尿良性MCC,最大膀胱容量;空后残尿量;Rej,逆行射精;经尿道前列腺切开;背景:良性前列腺增生是刺激性排尿和梗阻性症状的集合,这些症状与膀胱排尿减少和尿液储存缺陷相一致。药物治疗是延缓并发症和减轻症状的常用治疗方法。西洛多辛是一种高选择性α -1a肾上腺素受体阻滞剂,对α -1a的亲和力是α - 1b的162倍,因此具有高的尿选择性和较低的副作用。目的:本文综述西洛多辛治疗前列腺增生的临床疗效、安全性和耐受性。方法:使用不同组合的相关关键词(如西洛多辛、低血压、良性前列腺增生),通过PubMed检索检索文献,不受发表日期和语言的限制。评估西洛多辛治疗疗效和耐受性的论文根据其与主题的相关性,由作者判断,被选择纳入。Overvıew临床资料:西洛多辛适用于治疗良性前列腺增生的体征和症状。它对有下尿路症状的男性起效迅速,在排尿和尿潴留症状、最大尿流率和与健康相关的生活质量方面均有改善。西洛多辛的疗效在一些对照研究和非干预性现实环境中得到了维持。西洛多辛总体耐受良好。结论:西洛多辛是泌尿选择性最强的α-阻滞剂。西洛多辛在2021年欧洲泌尿外科协会非神经源性男性LUTS保守治疗指南中得到了强调,据报道,西洛多辛的降压作用与安慰剂相当,并且具有良好的安全性和耐受性。西洛多辛的剂量不需要根据年龄调整,也不需要同时服用抗高血压药物和磷酸二酯酶5型抑制剂。
{"title":"The efficacy and safety of silodosin-a review of literature","authors":"Gokhan Faikoglu, Kubra Saygisever-Faikoglu, Fatmanur Otmar Ozcan, B. Berk","doi":"10.15406/ppij.2021.09.00353","DOIUrl":"https://doi.org/10.15406/ppij.2021.09.00353","url":null,"abstract":"clinical global ejaculation latency times; IPSS, international prostate symptom score; lower urinary tract lower urinary benign MCC, maximum cystometric capacity; postvoid residual urine volume; Rej, retrograde ejaculation; transurethral incision of the prostate; Background: Benign prostatic hyperplasia is a compilation of irritative voiding and obstructive symptoms which are consistent with reduced emptying of urine from and defective storage of urine in the bladder. Medications are a common method of treatment to delay complications and reduce symptoms. Silodosin is a highly selective alpha-1A adrenoceptor blocker that has 162 times more affinity for alpha-1a than alpha 1b, thus resulting in high uroselectivity and decreased side effects. Aim: In this review article our aim was to elucidate the clinical effects, safety and tolerability profile of silodosin in the treatment of benign prostatic hyperplasia. Method: Literatures were retrieved by a PubMed search, using different combinations of pertinent keywords (e.g., silodosin, hypotension, benign prostatic hyperplasia), without any limitations in terms of publication date and language. Papers which assessed the therapeutic efficacy and tolerability of silodosin were selected for inclusion according to their relevance for the topic, as judged by the authors. Overvıew of clinical data: Silodosin is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia. It has a rapid onset of effect in men with lower urinary tract symptoms and improvements were seen in voiding and storage symptoms, maximum urinary flow rate and health-related quality of life. The efficacy of silodosin was maintained in several controlled studies and also non-interventional real-world setting. Silodosin was generally well tolerated. Conclusion: Silodosin is the most uroselective α-blocker. Silodosin has been emphasized in the 2021 European Association of Urology Conservative treatment of non-neurogenic male LUTS guidelines and it has been reported that the hypotensive effect of silodosin is comparable with placebo and has favorable safety and tolerability profile. Dosing of silodosin does not need to be adjusted according to age, concurrent medication with antihypertensives and phosphodiesterase type 5 inhibitors.","PeriodicalId":19839,"journal":{"name":"Pharmacy & Pharmacology International Journal","volume":"58 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74641030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tribenoside–lidocaine combination in wound healing of hemorrhoids: a review of literature 三苯诺与利多卡因联合治疗痔疮创面愈合的文献综述
Pub Date : 2021-11-17 DOI: 10.15406/ppij.2021.09.00351
Gokhan Faikoglu, Kubra Saygisever-Faikoglu, F. Ozcan
Background: Hemorrhoids are one of the most common anorectal disease observed in clinical practice. Symptomatic hemorrhoids can be effectively treated with a pharmacological approach, particularly with topical drugs, associated with dietary and lifestyle changes. this review is to assess the effectiveness of tribenoside 5% + lidocaine 2% combination cream and suppository forms to manage the acute symptomatology of patients with hemorrhoids. Method: Literatures were re trieved by a PubMed search, using different com binations of pertinent keywords (e.g., wound healing, tribeno side, hemorrhoids), without any limitations in terms of publication date and language. Papers which assessed the therapeutic efficacy and tolerability of tribenoside + lidocaine combination in patients with hemorrhoids were se lected for inclusion according to their relevance for the topic, as judged by the authors. Results: Five studies compared tribenoside + lidocaine combination with each of its single components: in 3 studies tribenoside + lidocaine was compared with lidocaine and in 2 studies with tribenoside. Moreover in 6 studies tribenoside + lidocaine has been compared with a corticosteroid containing preparation and 2 studies evaluated the product effectiveness in women with hemorrhoids, as a consequence of pregnancy or delivery. The results of all studies showed that the association tribenoside + lidocaine was significantly superior to lidocaine alone and had a similar clinical efficacy compared to tribenoside and corticosteroids. However, the tribenoside + lidocaine showed a faster relief of subjective symptomatology, than tribenoside and corticosteroids, with the advantage to avoid the possible steroid-related side-effects. Tribenoside + lidocaine has been well tolerated. Conclusion: In conclusion, tribenoside + lidocaine represents a rapid, effective and safe option for treatment of hemorrhoids, and should be recommended as first-line treatment of this disease in clinical practice for its long-lasting healing effects on hemorrhoids with high efficacy and good tolerability. first study was a randomized double-blind study comparing tribenoside+lidocaine cream (n=14) with lidocaine 2% cream (n=14) . The 2nd and 3th were open-label investigations with tribenoside+lidocaine cream (n=60) and suppositories (n=44) The 4th study compared preparations (hydrocortisone triamcinolone prednisolone (n=45)). times daily for 10 days (post-partum) or 20 days (pregnancy). Results were rated as excellent in 15, good in 18 and minimal in 7 patients (globally good or very good results in 82.5% of subjects) . Tolerability was favorable in all cases and no systemic or local adverse effects have been observed. 19
背景:痔疮是临床上最常见的肛肠疾病之一。有症状的痔疮可以通过药理学方法有效治疗,特别是局部用药,与饮食和生活方式的改变有关。本综述旨在评价5%三苯苷+ 2%利多卡因联合乳膏和栓剂治疗痔疮患者急性症状的有效性。方法:通过PubMed检索检索相关关键词(如:创面愈合、三苯侧、痔疮)的不同组合检索文献,不受发表日期和语言的限制。评估三苯醚+利多卡因联合治疗痔疮患者的疗效和耐受性的论文,根据其与主题的相关性,由作者判断,选择纳入。结果:有5项研究比较了三苯诺苷+利多卡因联合用药及其各单一成分的差异:3项研究比较了三苯诺苷+利多卡因与利多卡因的差异,2项研究比较了三苯诺苷与利多卡因的差异。此外,在6项研究中,将三苯苷+利多卡因与含有皮质类固醇的制剂进行了比较,2项研究评估了该产品对因妊娠或分娩而患痔疮的妇女的有效性。所有研究结果均表明,三苯醚+利多卡因联合治疗明显优于单独使用利多卡因,临床疗效与三苯醚+糖皮质激素相似。然而,三苯醚+利多卡因对主观症状的缓解速度比三苯醚+皮质类固醇更快,并且可以避免可能出现的类固醇相关副作用。三苯诺苷+利多卡因耐受性良好。结论:综上所述,三苯皂苷+利多卡因治疗痔疮是一种快速、有效、安全的治疗方案,临床上应推荐作为本病的一线治疗方案,其对痔疮的愈合效果持久,疗效高,耐受性好。第一项研究是一项随机双盲研究,比较三苯苷+利多卡因乳膏(n=14)和2%利多卡因乳膏(n=14)。第2和第3项是开放标签研究,使用三苯诺苷+利多卡因乳膏(n=60)和栓剂(n=44)。第4项研究比较了制剂(氢化可的松曲安奈德和强的松龙(n=45))。每天10次(产后)或20天(怀孕)。15名患者的结果被评为优秀,18名患者被评为良好,7名患者被评为最低(总体而言,82.5%的受试者结果为良好或非常好)。所有病例耐受性良好,未观察到全身或局部不良反应。19
{"title":"Tribenoside–lidocaine combination in wound healing of hemorrhoids: a review of literature","authors":"Gokhan Faikoglu, Kubra Saygisever-Faikoglu, F. Ozcan","doi":"10.15406/ppij.2021.09.00351","DOIUrl":"https://doi.org/10.15406/ppij.2021.09.00351","url":null,"abstract":"Background: Hemorrhoids are one of the most common anorectal disease observed in clinical practice. Symptomatic hemorrhoids can be effectively treated with a pharmacological approach, particularly with topical drugs, associated with dietary and lifestyle changes. this review is to assess the effectiveness of tribenoside 5% + lidocaine 2% combination cream and suppository forms to manage the acute symptomatology of patients with hemorrhoids. Method: Literatures were re trieved by a PubMed search, using different com binations of pertinent keywords (e.g., wound healing, tribeno side, hemorrhoids), without any limitations in terms of publication date and language. Papers which assessed the therapeutic efficacy and tolerability of tribenoside + lidocaine combination in patients with hemorrhoids were se lected for inclusion according to their relevance for the topic, as judged by the authors. Results: Five studies compared tribenoside + lidocaine combination with each of its single components: in 3 studies tribenoside + lidocaine was compared with lidocaine and in 2 studies with tribenoside. Moreover in 6 studies tribenoside + lidocaine has been compared with a corticosteroid containing preparation and 2 studies evaluated the product effectiveness in women with hemorrhoids, as a consequence of pregnancy or delivery. The results of all studies showed that the association tribenoside + lidocaine was significantly superior to lidocaine alone and had a similar clinical efficacy compared to tribenoside and corticosteroids. However, the tribenoside + lidocaine showed a faster relief of subjective symptomatology, than tribenoside and corticosteroids, with the advantage to avoid the possible steroid-related side-effects. Tribenoside + lidocaine has been well tolerated. Conclusion: In conclusion, tribenoside + lidocaine represents a rapid, effective and safe option for treatment of hemorrhoids, and should be recommended as first-line treatment of this disease in clinical practice for its long-lasting healing effects on hemorrhoids with high efficacy and good tolerability. first study was a randomized double-blind study comparing tribenoside+lidocaine cream (n=14) with lidocaine 2% cream (n=14) . The 2nd and 3th were open-label investigations with tribenoside+lidocaine cream (n=60) and suppositories (n=44) The 4th study compared preparations (hydrocortisone triamcinolone prednisolone (n=45)). times daily for 10 days (post-partum) or 20 days (pregnancy). Results were rated as excellent in 15, good in 18 and minimal in 7 patients (globally good or very good results in 82.5% of subjects) . Tolerability was favorable in all cases and no systemic or local adverse effects have been observed. 19","PeriodicalId":19839,"journal":{"name":"Pharmacy & Pharmacology International Journal","volume":"74 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91344224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The effectively of favipiravir as antiviral therapy in the treatment of covid-19 in the several hospital in Blora, Indonesia 在印度尼西亚博罗拉的几家医院中,法匹拉韦作为抗病毒疗法治疗covid-19的有效性
Pub Date : 2021-11-05 DOI: 10.15406/ppij.2021.09.00349
Metrikana Novembrina, Ayu Anggara Ati
The outbreak of Corona virus Disease 2019 (COVID-19) in December 2019 in China, has become a pandemic in March 2020. A clinical study in China on the effectiveness of favipiravir involving 320 COVID-19 patients stated that favipiravir was safe and efficacious in the treatment of COVID-19. However, in Indonesia, the clinical studies on the effectiveness and the toxicity of the antiviral are so lacking that the further research will be needed. The objective of the study is to analize the effectiveness of favipiravir as an antiviral therapy in the treatment of COVID-19 in several hospital in the district of Blora, Central Java, Indonesia. In this study as many as 266 samples of the patient’s medical record which met the inclusion criteria were devided into group 1 which given favipiravir and group 2 which not given favipirafir. Data were then analized by using chi-square with continuity correction to evaluate the difference in proportion of those who were given the antiviral and those who were not, in relation to the outcome. The result showed that as many as 92.5% of the patient given favipiravir showed an improved outcome and 7.5% of those were reported dead. As many as 80.5% of those not given favipiravir showed an improved outcome and 19.5% of those were reported dead. Based on the chi square with continuity correction, it revealed that there was significant difference in the proportion among the groups in relation to the outcome (p<0,05). Based on the results and discussions, it is concluded that favipiravir is effective to be used as an antiviral drug in the treatment of COVID-19.
2019年12月在中国爆发的2019冠状病毒病(COVID-19)已于2020年3月成为大流行。国内一项涉及320例新冠肺炎患者的法匹拉韦疗效临床研究表明,法匹拉韦治疗新冠肺炎安全有效。然而,在印度尼西亚,关于抗病毒药物的有效性和毒性的临床研究非常缺乏,需要进一步的研究。该研究的目的是分析favipiravir作为抗病毒疗法在印度尼西亚中爪哇省Blora区的几家医院治疗COVID-19的有效性。本研究将266份符合纳入标准的患者病历样本分为给予法匹拉韦的第1组和未给予法匹拉韦的第2组。然后使用连续性校正的卡方对数据进行分析,以评估给予抗病毒药物的患者和未给予抗病毒药物的患者的比例与结果的差异。结果显示,服用favipiravir的患者中,92.5%的患者预后有所改善,其中7.5%的患者死亡。80.5%未服用favipiravir的患者表现出好转,19.5%的患者死亡。经连续性校正的卡方分析显示,组间比例与结果有显著性差异(p< 0.05)。综合以上结果和讨论,认为favipiravir可作为抗病毒药物用于COVID-19的治疗。
{"title":"The effectively of favipiravir as antiviral therapy in the treatment of covid-19 in the several hospital in Blora, Indonesia","authors":"Metrikana Novembrina, Ayu Anggara Ati","doi":"10.15406/ppij.2021.09.00349","DOIUrl":"https://doi.org/10.15406/ppij.2021.09.00349","url":null,"abstract":"The outbreak of Corona virus Disease 2019 (COVID-19) in December 2019 in China, has become a pandemic in March 2020. A clinical study in China on the effectiveness of favipiravir involving 320 COVID-19 patients stated that favipiravir was safe and efficacious in the treatment of COVID-19. However, in Indonesia, the clinical studies on the effectiveness and the toxicity of the antiviral are so lacking that the further research will be needed. The objective of the study is to analize the effectiveness of favipiravir as an antiviral therapy in the treatment of COVID-19 in several hospital in the district of Blora, Central Java, Indonesia. In this study as many as 266 samples of the patient’s medical record which met the inclusion criteria were devided into group 1 which given favipiravir and group 2 which not given favipirafir. Data were then analized by using chi-square with continuity correction to evaluate the difference in proportion of those who were given the antiviral and those who were not, in relation to the outcome. The result showed that as many as 92.5% of the patient given favipiravir showed an improved outcome and 7.5% of those were reported dead. As many as 80.5% of those not given favipiravir showed an improved outcome and 19.5% of those were reported dead. Based on the chi square with continuity correction, it revealed that there was significant difference in the proportion among the groups in relation to the outcome (p<0,05). Based on the results and discussions, it is concluded that favipiravir is effective to be used as an antiviral drug in the treatment of COVID-19.","PeriodicalId":19839,"journal":{"name":"Pharmacy & Pharmacology International Journal","volume":"53 76 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88568988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell death induction of dibutyl phthalate (DBP) on primary brain cells from adult zebrafish 邻苯二甲酸二丁酯(DBP)对成年斑马鱼原代脑细胞的细胞死亡诱导
Pub Date : 2021-10-29 DOI: 10.15406/ppij.2021.09.00348
B. Zayas, Gloria Carrasquillo, Naysha Pinet-Velez, C. Vélez, J. Ortiz
The presence of phthalates as plasticizer on pharmaceutical products as well as in aquatic environments requires serious attention. Phthalates are compounds widely used in the manufacturing industry and has been associate with multiple adverse health effects to human. Among the family of phthalates Dibutyl phthalate (DBP) is well used for pharmaceutical products. Limited information however has been generated on the effect of DBP on the brain. The objective of this investigation was to characterize potential neurotoxicity resulting from short term exposure to DBP. Considering the efficacy and sensitivity of the zebrafish model as an early stage- screening tool, and their neurological and biochemical similarities to those of human, this study evaluates the effect of DBP on primary brain cells of the adult zebrafish. This well optimized and implemented methodology can be consider a guide for future studies using primary cells of adult zebrafish given the reduction on reagents, and the number of cells used for treatment. For indirect confirmation of extracted nervous tissue, the Acetylcholinesterase activity (AChEs) assay kit was implemented. In our study primary cells from adult zebrafish brain were exposed to DBP for 24 hours at aerobic environment at concentrations from 3uM to 100μM. The effect on cell viability as well as cell death mechanisms was determined. Results indicate that adult primary brain cells viability is compromised as low as 8uM of DBP. In terms of mechanism, cells undergo apoptosis and autophagy at concentrations of 8μM and 100μM. This study confirms that low concentrations of DBP over a 24-hour period induces apoptosis and autophagy, potentially activating degradation of brain cells and altering biochemical processes of the nervous system. This research presents a novel approach for future molecular studies using brain primary cells as model to screen pharmaceuticals and environmental agents for risk assessment.
作为增塑剂的邻苯二甲酸盐存在于医药产品以及水生环境中,需要引起高度重视。邻苯二甲酸酯是一种广泛应用于制造业的化合物,对人体健康有多种不良影响。在邻苯二甲酸酯家族中,邻苯二甲酸二丁酯(DBP)广泛用于医药产品。然而,关于DBP对大脑的影响的信息有限。本研究的目的是表征短期暴露于DBP所造成的潜在神经毒性。考虑到斑马鱼模型作为早期筛选工具的有效性和敏感性,以及它们与人类的神经和生化相似性,本研究评估了DBP对成年斑马鱼初级脑细胞的影响。考虑到试剂的减少和用于处理的细胞数量,这种优化和实施的方法可以被认为是未来使用成年斑马鱼原代细胞进行研究的指南。为间接确认提取的神经组织,采用乙酰胆碱酯酶活性(AChEs)测定试剂盒。在我们的研究中,成年斑马鱼大脑的原代细胞在有氧环境中暴露于浓度为3uM至100μM的DBP 24小时。确定了对细胞活力的影响以及细胞死亡机制。结果表明,成人初级脑细胞的活力在低至8uM DBP时受到损害。机制方面,8μM和100μM浓度下细胞发生凋亡和自噬。本研究证实,24小时内低浓度DBP可诱导细胞凋亡和自噬,潜在地激活脑细胞的降解并改变神经系统的生化过程。本研究为未来以脑原代细胞为模型筛选药物和环境因子进行风险评估的分子研究提供了一种新的方法。
{"title":"Cell death induction of dibutyl phthalate (DBP) on primary brain cells from adult zebrafish","authors":"B. Zayas, Gloria Carrasquillo, Naysha Pinet-Velez, C. Vélez, J. Ortiz","doi":"10.15406/ppij.2021.09.00348","DOIUrl":"https://doi.org/10.15406/ppij.2021.09.00348","url":null,"abstract":"The presence of phthalates as plasticizer on pharmaceutical products as well as in aquatic environments requires serious attention. Phthalates are compounds widely used in the manufacturing industry and has been associate with multiple adverse health effects to human. Among the family of phthalates Dibutyl phthalate (DBP) is well used for pharmaceutical products. Limited information however has been generated on the effect of DBP on the brain. The objective of this investigation was to characterize potential neurotoxicity resulting from short term exposure to DBP. Considering the efficacy and sensitivity of the zebrafish model as an early stage- screening tool, and their neurological and biochemical similarities to those of human, this study evaluates the effect of DBP on primary brain cells of the adult zebrafish. This well optimized and implemented methodology can be consider a guide for future studies using primary cells of adult zebrafish given the reduction on reagents, and the number of cells used for treatment. For indirect confirmation of extracted nervous tissue, the Acetylcholinesterase activity (AChEs) assay kit was implemented. In our study primary cells from adult zebrafish brain were exposed to DBP for 24 hours at aerobic environment at concentrations from 3uM to 100μM. The effect on cell viability as well as cell death mechanisms was determined. Results indicate that adult primary brain cells viability is compromised as low as 8uM of DBP. In terms of mechanism, cells undergo apoptosis and autophagy at concentrations of 8μM and 100μM. This study confirms that low concentrations of DBP over a 24-hour period induces apoptosis and autophagy, potentially activating degradation of brain cells and altering biochemical processes of the nervous system. This research presents a novel approach for future molecular studies using brain primary cells as model to screen pharmaceuticals and environmental agents for risk assessment.","PeriodicalId":19839,"journal":{"name":"Pharmacy & Pharmacology International Journal","volume":"30 11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78629001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of dried ginger water extract on hypertriglyceridemia induced acute pancreatitis in rats 干姜水提取物对高甘油三酯血症大鼠急性胰腺炎的影响
Pub Date : 2021-10-26 DOI: 10.15406/ppij.2021.09.00347
Pratap K Khunti, Samir Rabadiya, Jalpa Sanandiya, S. Parmar
Background/objectives: Acute pancreatitis (AP) is characterized by tissue edema, acinar necrosis, hemorrhage, and fat necrosis, as well as inflammation and perivascular infiltration in the pancreas. Serum triglyceride levels more than 1000 mg/dl are accountable for AP. Ginger extract has been reported to reduce the triglyceride level in diabetic rats. This study is aimed to determine the effect of ginger water extract on AP in rats. Methods: Hypertriglyceridemic-AP was induced by poloxamer 407 (0.7 gm/kg) in Wistar rats. The treatment of ginger water extract was given in two groups with doses of 200 and 400 mg/kg in the rats. The effect of ginger water extract on serum blood glucose, triglyceride, and lipoprotein profile was estimated to access its lipid-lowering properties. The effect of ginger water extract on lipid peroxidation, superoxide dismutase, catalase, and glutathione was also studied. Results: Ginger extract showed significantly reduced blood glucose, triglyceride, total cholesterol, α-amylase, and increased good cholesterol levels compared to the disease control group that indicated beneficial lipid-lowering properties. Furthermore, ginger water extract was also significantly reduced lipid peroxidation and enhanced superoxide dismutase, catalase, and glutathione levels as compared with the disease control group. Conclusion: In conclusion, the ameliorative effect of ginger extract against poloxamer 407 induced HTG-AP. Demonstrated lipid-lowering and antioxidant properties of ginger extract. The present study, showed protective effect of ginger against Acute Pancreatitis in rats.
背景/目的:急性胰腺炎(AP)的特征是组织水肿、腺泡坏死、出血、脂肪坏死,以及胰腺的炎症和血管周围浸润。血清甘油三酯水平超过1000毫克/分升是导致AP的原因。据报道,生姜提取物可以降低糖尿病大鼠的甘油三酯水平。本研究旨在探讨姜水提取物对大鼠AP的影响。方法:用波洛沙姆407 (0.7 gm/kg)诱导Wistar大鼠高甘油三酯血症。大鼠分为两组,剂量分别为200和400 mg/kg。生姜水提取物对血清血糖、甘油三酯和脂蛋白谱的影响估计达到其降脂特性。研究了生姜水提物对脂质过氧化、超氧化物歧化酶、过氧化氢酶和谷胱甘肽的影响。结果:与疾病对照组相比,生姜提取物能显著降低血糖、甘油三酯、总胆固醇、α-淀粉酶,并提高有益胆固醇水平,显示出有益的降脂特性。此外,与疾病对照组相比,生姜水提取物还显著降低了脂质过氧化,提高了超氧化物歧化酶、过氧化氢酶和谷胱甘肽水平。结论:生姜提取物对poloxam407诱导的HTG-AP有改善作用。证明了生姜提取物的降脂和抗氧化特性。本研究显示生姜对大鼠急性胰腺炎有保护作用。
{"title":"Effect of dried ginger water extract on hypertriglyceridemia induced acute pancreatitis in rats","authors":"Pratap K Khunti, Samir Rabadiya, Jalpa Sanandiya, S. Parmar","doi":"10.15406/ppij.2021.09.00347","DOIUrl":"https://doi.org/10.15406/ppij.2021.09.00347","url":null,"abstract":"Background/objectives: Acute pancreatitis (AP) is characterized by tissue edema, acinar necrosis, hemorrhage, and fat necrosis, as well as inflammation and perivascular infiltration in the pancreas. Serum triglyceride levels more than 1000 mg/dl are accountable for AP. Ginger extract has been reported to reduce the triglyceride level in diabetic rats. This study is aimed to determine the effect of ginger water extract on AP in rats. Methods: Hypertriglyceridemic-AP was induced by poloxamer 407 (0.7 gm/kg) in Wistar rats. The treatment of ginger water extract was given in two groups with doses of 200 and 400 mg/kg in the rats. The effect of ginger water extract on serum blood glucose, triglyceride, and lipoprotein profile was estimated to access its lipid-lowering properties. The effect of ginger water extract on lipid peroxidation, superoxide dismutase, catalase, and glutathione was also studied. Results: Ginger extract showed significantly reduced blood glucose, triglyceride, total cholesterol, α-amylase, and increased good cholesterol levels compared to the disease control group that indicated beneficial lipid-lowering properties. Furthermore, ginger water extract was also significantly reduced lipid peroxidation and enhanced superoxide dismutase, catalase, and glutathione levels as compared with the disease control group. Conclusion: In conclusion, the ameliorative effect of ginger extract against poloxamer 407 induced HTG-AP. Demonstrated lipid-lowering and antioxidant properties of ginger extract. The present study, showed protective effect of ginger against Acute Pancreatitis in rats.","PeriodicalId":19839,"journal":{"name":"Pharmacy & Pharmacology International Journal","volume":"201 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82826435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prophylaxis of malaria by Artemisia infusions: The key role of lysine 青蒿注射液预防疟疾:赖氨酸的关键作用
Pub Date : 2021-10-08 DOI: 10.15406/ppij.2021.09.00346
P. Lutgen
Since several years we try to understand why Artemisia infusions show a very efficient prophylaxis against malaria. This has been noticed in clinical trials and anecdotic reports in several African countries. Patrick Ogwang in his seminal work finds that Artemisia annua infusion consumed once a week is effective in preventing multiple episodes of malaria attacks and its mode of action may involve stimulation of white blood cells production especially monocytes.1 We have proposed several hypotheses, but were so far unable to verify them in vivo.2,3 Another hypothesis was based on the oxidative weakening of sporozoites by NO generated by arginine. Scientific papers on this topic are scarce.4,5 Another explanation for the prophylactic effect is resting on the high concentration of fatty acids in medicinal plants, and particularly polyunsaturated fatty acids (PUFA). Preliminary studies had indicated to a research team in Norway a suppressive influence of fish oils on rodent malaria.6
几年来,我们一直在努力了解为什么注射青蒿能非常有效地预防疟疾。在一些非洲国家的临床试验和轶事报告中已经注意到这一点。Patrick Ogwang在他的开创性工作中发现,每周服用一次青蒿输注对预防多次疟疾发作有效,其作用方式可能涉及刺激白细胞产生,特别是单核细胞1我们提出了几个假设,但到目前为止还无法在体内验证。2,3另一种假设是基于精氨酸产生的NO对孢子体的氧化削弱。关于这个话题的科学论文很少。4,5对其预防作用的另一种解释是基于药用植物中高浓度的脂肪酸,特别是多不饱和脂肪酸(PUFA)。初步研究向挪威的一个研究小组表明,鱼油对啮齿动物的疟疾有抑制作用
{"title":"Prophylaxis of malaria by Artemisia infusions: The key role of lysine","authors":"P. Lutgen","doi":"10.15406/ppij.2021.09.00346","DOIUrl":"https://doi.org/10.15406/ppij.2021.09.00346","url":null,"abstract":"Since several years we try to understand why Artemisia infusions show a very efficient prophylaxis against malaria. This has been noticed in clinical trials and anecdotic reports in several African countries. Patrick Ogwang in his seminal work finds that Artemisia annua infusion consumed once a week is effective in preventing multiple episodes of malaria attacks and its mode of action may involve stimulation of white blood cells production especially monocytes.1 We have proposed several hypotheses, but were so far unable to verify them in vivo.2,3 Another hypothesis was based on the oxidative weakening of sporozoites by NO generated by arginine. Scientific papers on this topic are scarce.4,5 Another explanation for the prophylactic effect is resting on the high concentration of fatty acids in medicinal plants, and particularly polyunsaturated fatty acids (PUFA). Preliminary studies had indicated to a research team in Norway a suppressive influence of fish oils on rodent malaria.6","PeriodicalId":19839,"journal":{"name":"Pharmacy & Pharmacology International Journal","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87880553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In-vivo studies to manifest the potent antiinflammatory and analgesic effect of the topical formulation, Pankajakasthuri orthoherb cream/ thermagel upon single application in wistar albino rats 体内研究表明局部配方Pankajakasthuri orthoherb cream/ thermagel在wistar白化大鼠单次应用后具有有效的抗炎和镇痛作用
Pub Date : 2021-09-22 DOI: 10.15406/ppij.2021.09.00345
Shan Sasidharan, Hareendran Nair J
Pain and inflammation are the most common and prominent symptoms of many diseases. Inflammation is the most pivotal response of a damaged tissue that induces various hostile stimuli such as infections, toxic chemical agents, and physical damage resulting in redness, edema, heat, and pain. Diclofenac sodium is the most widely prescribed medicine in the management of pain and inflammation. Lamentably, long-term use of this drug causes multiple harmful side effects. To overcome this, we have formulated Pankajakasthuri orthoherb cream/thermagel, a polyherbal topical preparation for inflammation and pain relief. The objective of the present study was to assess the anti-inflammatory and analgesic potential of Pankajakasthuri orthoherb cream/thermagel , when administered topically, using carrageenan-induced edema and formalin testing in experimental animals. Here, diclofenac sodium gel was used as a positive control for anti-inflammatory and analgesic activity. From the results of our study, it was clear that Pankajakasthuri orthoherb cream/ thermagel significantly inhibited the formation of the rat paw edema and this effect was significantly better than standard diclofenac sodium gel. Pankajakasthuri orthoherb cream/ thermagel recorded a positive result after 3 h of treatment and maximum reduction in edema was recorded after 18 h of treatment (96.72%). The analgesic effect of Pankajakasthuri orthoherb cream/thermagel was recorded mainly in the late phase (70.70%). This suggests that the activity may be due to peripheral action, when compared with the action of diclofenac sodium gel. Hence it can be concluded that Pankajakasthuri orthoherb cream/ thermagel can result in better anti-inflammatory and analgesic action for a longer duration upon single application compared with standard diclofenac sodium gel.
疼痛和炎症是许多疾病最常见和最突出的症状。炎症是受损组织最关键的反应,它诱发各种敌对刺激,如感染、有毒化学物质和导致红肿、水肿、发热和疼痛的物理损伤。双氯芬酸钠是治疗疼痛和炎症最广泛的处方药。遗憾的是,长期使用这种药物会导致多种有害的副作用。为了克服这个问题,我们制定了Pankajakasthuri orthoherb cream/thermagel,这是一种用于缓解炎症和疼痛的多草药局部制剂。本研究的目的是评估Pankajakasthuri orthoherb cream/thermagel在局部给药时的抗炎和镇痛潜力,在实验动物中使用卡拉胶诱导水肿和福尔马林测试。在这里,双氯芬酸钠凝胶被用作抗炎和镇痛活性的阳性对照。从我们的研究结果可以看出,Pankajakasthuri orthoherb cream/ thermagel明显抑制大鼠足部水肿的形成,其效果明显优于标准双氯芬酸钠凝胶。Pankajakasthuri orthoherb cream/ thermagel治疗3 h后显示阳性,治疗18 h后水肿减少最大(96.72%)。原植草膏/热疗膏的镇痛作用主要发生在后期(70.70%)。这表明,与双氯芬酸钠凝胶的作用相比,活性可能是由于外周作用。由此可以得出结论,与标准双氯芬酸钠凝胶相比,Pankajakasthuri orthoherb cream/ thermagel单次应用具有更好的抗炎和镇痛作用,持续时间更长。
{"title":"In-vivo studies to manifest the potent antiinflammatory and analgesic effect of the topical formulation, Pankajakasthuri orthoherb cream/ thermagel upon single application in wistar albino rats","authors":"Shan Sasidharan, Hareendran Nair J","doi":"10.15406/ppij.2021.09.00345","DOIUrl":"https://doi.org/10.15406/ppij.2021.09.00345","url":null,"abstract":"Pain and inflammation are the most common and prominent symptoms of many diseases. Inflammation is the most pivotal response of a damaged tissue that induces various hostile stimuli such as infections, toxic chemical agents, and physical damage resulting in redness, edema, heat, and pain. Diclofenac sodium is the most widely prescribed medicine in the management of pain and inflammation. Lamentably, long-term use of this drug causes multiple harmful side effects. To overcome this, we have formulated Pankajakasthuri orthoherb cream/thermagel, a polyherbal topical preparation for inflammation and pain relief. The objective of the present study was to assess the anti-inflammatory and analgesic potential of Pankajakasthuri orthoherb cream/thermagel , when administered topically, using carrageenan-induced edema and formalin testing in experimental animals. Here, diclofenac sodium gel was used as a positive control for anti-inflammatory and analgesic activity. From the results of our study, it was clear that Pankajakasthuri orthoherb cream/ thermagel significantly inhibited the formation of the rat paw edema and this effect was significantly better than standard diclofenac sodium gel. Pankajakasthuri orthoherb cream/ thermagel recorded a positive result after 3 h of treatment and maximum reduction in edema was recorded after 18 h of treatment (96.72%). The analgesic effect of Pankajakasthuri orthoherb cream/thermagel was recorded mainly in the late phase (70.70%). This suggests that the activity may be due to peripheral action, when compared with the action of diclofenac sodium gel. Hence it can be concluded that Pankajakasthuri orthoherb cream/ thermagel can result in better anti-inflammatory and analgesic action for a longer duration upon single application compared with standard diclofenac sodium gel.","PeriodicalId":19839,"journal":{"name":"Pharmacy & Pharmacology International Journal","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88907119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pongamia pinnata: an updated review on its phytochemistry, & pharmacological uses 桄榔子:植物化学和药理应用的最新进展
Pub Date : 2021-09-17 DOI: 10.15406/ppij.2021.09.00344
Saurabh Nimesh, M. Akram, Muhammad Amjad Chishti, Md. Iftekhar Ahmad, Shikha Dhama, M. Lal
P. pinnata, Pongamia pinnata; E. coli, Escherichia coli; PPEt, Pongamia pinnata leaf extract; HSV, herpes simplex virus; BW, body weight; IP, Intraperitoneal; PPSB, Pongamia pinnata stem bark; P. aeruginosa, Pseudomonas aeruginosa; S. aureus Staphylococcus aureus Abstract The term herb is also acknowledged as botanical medication or usage of herb-based traditional medicinal practice in herbal medicine, and it refers to a herb or plant component that is utilized to formulate remedy to aid in the therapeutic procedure through sickness and ailment. Medicinal plants play an important role in both herbal medicine and modern pharmaceuticals. Pongamia pinnata (P. pinnata) has been recognized in different schemes of herbal medication for the treatment of a variety of diseases and ailments in humans. It comprises a variety of phytoconstituents and has a broad variety of pharmacological properties. Because of its thick network of lateral roots, it is a favored plant for managing earth corrosion and connecting sand mounds. The most significant properties of P. pinnata is that it can be used as biofuel besides used in the treatment of many diseases like cancers, stiff joints, hemorrhoids, bowel movement, vaginopathy, wound healing, cardioprotective, etc. This analysis examines existing knowledge of common uses, phytochemistry, and biological activities, as well as limitations that require future study.
凤尾花,凤尾花;大肠杆菌;大肠杆菌;pet,桄榔子叶提取物;单纯疱疹病毒;BW:体重;IP,腹腔内;PPSB, Pongamia pinnata茎皮;铜绿假单胞菌;草药一词也被认为是植物药物或草药中以草药为基础的传统医学实践的用法,它指的是用于制定补救措施以帮助治疗疾病和疾病的草药或植物成分。药用植物在中草药和现代医药中都占有重要的地位。凤尾花(凤尾花)已被确认在不同方案的草药治疗各种疾病和疾病的人类。它包含多种植物成分,具有广泛的药理特性。由于其厚厚的侧根网络,它是管理土壤腐蚀和连接沙丘的首选植物。它最显著的特性是除了用于治疗癌症、关节僵硬、痔疮、排便、阴道病、伤口愈合、心脏保护等许多疾病外,还可以用作生物燃料。本分析考察了常见用途、植物化学和生物活动的现有知识,以及需要未来研究的局限性。
{"title":"Pongamia pinnata: an updated review on its phytochemistry, & pharmacological uses","authors":"Saurabh Nimesh, M. Akram, Muhammad Amjad Chishti, Md. Iftekhar Ahmad, Shikha Dhama, M. Lal","doi":"10.15406/ppij.2021.09.00344","DOIUrl":"https://doi.org/10.15406/ppij.2021.09.00344","url":null,"abstract":"P. pinnata, Pongamia pinnata; E. coli, Escherichia coli; PPEt, Pongamia pinnata leaf extract; HSV, herpes simplex virus; BW, body weight; IP, Intraperitoneal; PPSB, Pongamia pinnata stem bark; P. aeruginosa, Pseudomonas aeruginosa; S. aureus Staphylococcus aureus Abstract The term herb is also acknowledged as botanical medication or usage of herb-based traditional medicinal practice in herbal medicine, and it refers to a herb or plant component that is utilized to formulate remedy to aid in the therapeutic procedure through sickness and ailment. Medicinal plants play an important role in both herbal medicine and modern pharmaceuticals. Pongamia pinnata (P. pinnata) has been recognized in different schemes of herbal medication for the treatment of a variety of diseases and ailments in humans. It comprises a variety of phytoconstituents and has a broad variety of pharmacological properties. Because of its thick network of lateral roots, it is a favored plant for managing earth corrosion and connecting sand mounds. The most significant properties of P. pinnata is that it can be used as biofuel besides used in the treatment of many diseases like cancers, stiff joints, hemorrhoids, bowel movement, vaginopathy, wound healing, cardioprotective, etc. This analysis examines existing knowledge of common uses, phytochemistry, and biological activities, as well as limitations that require future study.","PeriodicalId":19839,"journal":{"name":"Pharmacy & Pharmacology International Journal","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80193231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Pharmacy & Pharmacology International Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1